Pages that link to "Q28196648"
Jump to navigation
Jump to search
The following pages link to Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer (Q28196648):
Displaying 26 items.
- Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis (Q28166676) (← links)
- (Q28173371) (redirect page) (← links)
- Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study (Q28476849) (← links)
- The case for developing publicly-accessible datasets for health services research in the Middle East and North Africa (MENA) region (Q33513734) (← links)
- Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis (Q33614082) (← links)
- Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk (Q34179634) (← links)
- Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk (Q34325928) (← links)
- Chemoprevention of prostate cancer: what can be recommended to patients? (Q34606617) (← links)
- Aspirin and urologic cancer risk: an update (Q34635300) (← links)
- Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies (Q35136401) (← links)
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study (Q36075269) (← links)
- Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006 (Q36241844) (← links)
- Management of prostate cancer. Part 1: chemoprevention (Q36407468) (← links)
- Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer? (Q37141642) (← links)
- Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer (Q37155271) (← links)
- Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. (Q37578293) (← links)
- Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk (Q37877878) (← links)
- Inflammation and prostate carcinogenesis (Q38031257) (← links)
- Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status (Q41184528) (← links)
- Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines (Q42180829) (← links)
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study. (Q42373340) (← links)
- Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis (Q43187352) (← links)
- Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study (Q45331811) (← links)
- Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). (Q53068177) (← links)
- Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. (Q55312563) (← links)
- Intake of Non-steroidal Anti-inflammatory Drugs and the Risk of Prostate Cancer: A Meta-Analysis (Q58573444) (← links)